Securities Class Action Against MannKind Dismissed

VALENCIA, Calif., Aug. 25, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation MNKD MNKD announced that the United States District Court for the Central District of California has dismissed the class action that was pending against MannKind Corporation and two of its executives.  The Court granted the defendants' motion to dismiss the plaintiffs' amended class action complaint without leave to amend, thereby closing the case.  The plaintiffs can appeal the decision within 30 days.

ABOUT MANNKIND CORPORATION
MannKind Corporation MNKD MNKD focuses on the discovery and development of therapeutic products for patients with diseases such as diabetes.  MannKind maintains a website at www.mannkindcorp.com to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.